2025
SJR Q2
JCR Q2 · 1,3
5 matched articles
SCIE
Journal detail
Journal of Biopharmaceutical Statistics
- Publisher
- Taylor and Francis Ltd.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1054340615205711
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,68
- Quartile Q2
- H-Index 60
- Cites/doc 1,26
- Docs (3y) 216
- Cites (3y) 313
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 1,3
- 5Y JIF 1,4
- JCI 0,59
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmacology Q2
- Pharmacology (medical) Q2
- Statistics and Probability Q2
Areas
- Mathematics
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy | Statistics & Probability
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,68 | 1,3 | 1,4 | 0,59 | Q2 | 60 |
| 2024 | Q2 | Q2 | 0,565 | 1,2 | 1,3 | 0,55 | Q2 | 58 |
| 2023 | Q2 | Q2 | 0,812 | 1,2 | 1,3 | 0,5 | Q3 | 58 |
| 2022 | Q2 | Q3 | 0,721 | 1,1 | 1,1 | 0,43 | Q3 | 58 |
| 2021 | Q2 | Q3 | 0,679 | 1,5 | 1,2 | 0,44 | Q3 | 58 |
| 2020 | Q3 | Q3 | 0,557 | 1,1 | 1 | 0,36 | Q3 | 58 |
| 2019 | Q2 | Q4 | 0,578 | 0,6 | 0,8 | 0,36 | Q3 | 58 |
| 2018 | — | Q3 | — | 0,8 | 0,8 | 0,38 | Q3 | — |
| 2017 | Q1 | Q4 | 1,294 | 0,6 | 0,9 | 0,41 | Q3 | 58 |
| 2016 | Q2 | Q3 | 0,609 | 1 | 0,8 | — | — | 58 |
| 2015 | Q2 | Q3 | 0,844 | 0,9 | 0,8 | — | — | 58 |
| 2014 | Q2 | Q4 | 0,737 | 0,6 | 0,9 | — | — | 58 |
| 2013 | Q1 | Q3 | 1,258 | 0,7 | 1,1 | — | — | 58 |
| 2012 | Q2 | Q3 | 0,793 | 0,7 | 1,2 | — | — | 58 |
| 2011 | Q2 | Q2 | 0,773 | 1,3 | 1,3 | — | — | 58 |
| 2010 | Q1 | Q2 | 1,064 | 1,1 | 1,3 | — | — | 58 |
| 2009 | — | Q2 | — | 1,1 | — | — | — | — |
| 2008 | — | Q3 | — | 1 | — | — | — | — |
| 2007 | — | Q3 | — | 0,8 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 299/356 |
| 2025 | STATISTICS & PROBABILITY | SCIE | Q2 | Q2 | 84/170 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 291/352 |
| 2024 | STATISTICS & PROBABILITY | SCIE | Q2 | Q2 | 79/169 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 290/354 |
| 2023 | STATISTICS & PROBABILITY | SCIE | Q2 | Q3 | 74/168 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 258/278 |
| 2022 | STATISTICS & PROBABILITY | SCIE | Q3 | Q3 | 82/125 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 253/279 |
| 2021 | STATISTICS & PROBABILITY | SCIE | Q3 | Q3 | 67/125 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 258/276 |
| 2020 | STATISTICS & PROBABILITY | SCIE | Q3 | Q3 | 91/125 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 261/271 |
| 2019 | STATISTICS & PROBABILITY | SCIE | Q4 | Q3 | 112/124 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 249/267 |
| 2018 | STATISTICS & PROBABILITY | SCIE | Q3 | Q3 | 87/123 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 246/261 |
| 2017 | STATISTICS & PROBABILITY | SCIE | Q4 | Q3 | 101/123 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 225/257 |
| 2016 | STATISTICS & PROBABILITY | SCIE | Q3 | — | 63/124 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 230/255 |
| 2015 | STATISTICS & PROBABILITY | SCIE | Q3 | — | 62/123 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 235/255 |
| 2014 | STATISTICS & PROBABILITY | SCIE | Q4 | — | 92/122 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 221/256 |
| 2013 | STATISTICS & PROBABILITY | SCIE | Q3 | — | 74/119 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 222/261 |
| 2012 | STATISTICS & PROBABILITY | SCIE | Q3 | — | 69/117 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 193/261 |
| 2011 | STATISTICS & PROBABILITY | SCIE | Q2 | — | 30/116 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 198/252 |
| 2010 | STATISTICS & PROBABILITY | SCIE | Q2 | — | 43/110 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 188/237 |
| 2009 | STATISTICS & PROBABILITY | SCIE | Q2 | — | 41/100 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 184/219 |
| 2008 | STATISTICS & PROBABILITY | SCIE | Q3 | — | 48/92 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 175/205 |
| 2007 | STATISTICS & PROBABILITY | SCIE | Q3 | — | 46/91 |